Works matching IS 17597706 AND DT 2023 AND VI 14 AND IP 11

Results: 10

Safety evaluation of immune checkpoint inhibitors combined with chemotherapy for the treatment of small cell lung cancer: A meta‐analysis of randomized controlled trials.

Published in:

Thoracic Cancer, 2023, v. 14, n. 11, p. 1029, doi. 10.1111/1759-7714.14842

By:

Longo, Vito;
Rizzo, Alessandro;
Catino, Annamaria;
Montrone, Michele;
Galetta, Domenico

Publication type:

Article

Segmentectomy versus lobectomy for small‐sized pure solid non–small cell lung cancer.

Published in:

Thoracic Cancer, 2023, v. 14, n. 11, p. 1021, doi. 10.1111/1759-7714.14840

By:

Li, Zhihua;
Xu, Wenzheng;
Pan, Xianglong;
Wu, Weibing;
Chen, Lian

Publication type:

Article

Epigenetic and genetic inactivation of tumor suppressor miR‐135a in non‐small‐cell lung cancer.

Published in:

Thoracic Cancer, 2023, v. 14, n. 11, p. 1012, doi. 10.1111/1759-7714.14838

By:

Choi, Jin Eun;
Jeon, Hyo Sung;
Wee, Hyun Jung;
Lee, Ji Yun;
Lee, Won Kee;
Lee, Shin Yup;
Yoo, Seung Soo;
Choi, Sun Ha;
Kim, Dong Sun;
Park, Jae Yong

Publication type:

Article

Exploratory analysis of immunochemotherapy compared to chemotherapy after EGFR‐TKI in non–small cell lung cancer patients with EGFR mutation: A multicenter retrospective study.

Published in:

Thoracic Cancer, 2023, v. 14, n. 11, p. 1004, doi. 10.1111/1759-7714.14836

By:

Hata, Tae;
Sakaguchi, Chikara;
Hirano, Keita;
Kobe, Hiroshi;
Ishida, Masaki;
Nakano, Takayuki;
Tachibana, Yusuke;
Tamiya, Nobuyo;
Shiotsu, Shinsuke;
Takeda, Takayuki;
Yamada, Tadaaki;
Yokoyama, Toshihide;
Tsuchiya, Michiko;
Nagasaka, Yukio

Publication type:

Article

Epidemiological landscape of esophageal cancer in Asia: Results from GLOBOCAN 2020.

Published in:

Thoracic Cancer, 2023, v. 14, n. 11, p. 992, doi. 10.1111/1759-7714.14835

By:

Zhu, Hongcheng;
Wang, Zezhou;
Deng, Bingbin;
Mo, Miao;
Wang, Honggang;
Chen, Ke;
Wu, Haoxuan;
Ye, Ting;
Wang, Boyan;
Ai, Dashan;
Hao, Shennan;
Tseng, Ihsuan;
Zhao, Kuaile

Publication type:

Article

Transformation or tumor heterogeneity: Mutations in EGFR, SOX2, TP53, and RB1 persist in the histological rapid conversion from lung adenocarcinoma to small‐cell lung cancer.

Published in:

Thoracic Cancer, 2023, v. 14, n. 11, p. 1036, doi. 10.1111/1759-7714.14832

By:

Hao, Lidan;
Chen, Haiyang;
Wang, Lili;
Zhou, Hanqiong;
Zhang, Zhe;
Han, Jing;
Hou, Jiabao;
Zhu, Yichen;
Zhang, He;
Wang, Qiming

Publication type:

Article

Carboxypeptidase vitellogenic like facilitates resistance to CDK4/6 inhibitors in breast cancer.

Published in:

Thoracic Cancer, 2023, v. 14, n. 11, p. 983, doi. 10.1111/1759-7714.14829

By:

Zhu, Xiang;
Xu, Xiaojie;
Zhang, Lin;
Yang, Xuhui

Publication type:

Article

SPATA2 suppresses epithelial‐mesenchymal transition to inhibit metastasis and radiotherapy sensitivity in non–small cell lung cancer via impairing DVL1/β‐catenin signaling.

Published in:

Thoracic Cancer, 2023, v. 14, n. 11, p. 969, doi. 10.1111/1759-7714.14828

By:

Ji, Hongbo;
Zhang, Lu;
Zou, Man;
Sun, Yanchen;
Dong, Xiaohan;
Mi, Zeyun;
Meng, Maobin;
Yuan, Zhiyong;
Wu, Zhiqiang

Publication type:

Article

Good practice: The experiences with the utilization of residual cancer burden—A single institution study.

Published in:

Thoracic Cancer, 2023, v. 14, n. 11, p. 963, doi. 10.1111/1759-7714.14826

By:

Sejben, Anita;
Hegedűs, Fanni;
Almási, Szintia;
Berta, Márton;
Oláh‐Németh, Orsolya;
Zombori, Tamás

Publication type:

Article

Issue Information.

Published in:: Thoracic Cancer, 2023, v. 14, n. 11, p. 961, doi. 10.1111/1759-7714.14497
Publication type:: Article